Items per page
Sort by

Send to:

Choose Destination

Results: 14

References for PMC Articles for PubMed (Select 22065675)


HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.

Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, Yamaguchi T, Ono M, Sakaguchi S, Matsuoka M.

PLoS Pathog. 2011 Feb 10;7(2):e1001274. doi: 10.1371/journal.ppat.1001274.


The HBZ gene, a key player in HTLV-1 pathogenesis.

Matsuoka M, Green PL.

Retrovirology. 2009 Aug 3;6:71. doi: 10.1186/1742-4690-6-71. Review.


Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.

Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, Barbeau B, Mahieux R.

Blood. 2009 Sep 17;114(12):2427-38. doi: 10.1182/blood-2008-09-179879. Epub 2009 Jul 14.


HTLV gene regulation: because size matters, transcription is not enough.

Journo C, Douceron E, Mahieux R.

Future Microbiol. 2009 May;4(4):425-40. doi: 10.2217/fmb.09.13. Review.


In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y.

Retrovirology. 2009 Feb 19;6:19. doi: 10.1186/1742-4690-6-19.


Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection.

Bartman MT, Kaidarova Z, Hirschkorn D, Sacher RA, Fridey J, Garratty G, Gibble J, Smith JW, Newman B, Yeo AE, Murphy EL; HTLV Outcomes Study (HOST) Investigators.

Blood. 2008 Nov 15;112(10):3995-4002. doi: 10.1182/blood-2008-05-155960. Epub 2008 Aug 28.


Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells.

Usui T, Yanagihara K, Tsukasaki K, Murata K, Hasegawa H, Yamada Y, Kamihira S.

Retrovirology. 2008 Apr 22;5:34. doi: 10.1186/1742-4690-5-34.


Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.

Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL; HTLV Outcomes Study (HOST) Investigators.

J Infect Dis. 2006 Dec 1;194(11):1557-64. Epub 2006 Oct 27.


HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.

Satou Y, Yasunaga J, Yoshida M, Matsuoka M.

Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5. Epub 2006 Jan 9. Erratum in: Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8906.


The epidemiology and disease outcomes of human T-lymphotropic virus type II.

Roucoux DF, Murphy EL.

AIDS Rev. 2004 Jul-Sep;6(3):144-54. Review.


Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.

Lee TH, Chafets DM, Busch MP, Murphy EL.

J Clin Virol. 2004 Dec;31(4):275-82.


Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.

Murphy EL, Glynn SA, Fridey J, Sacher RA, Smith JW, Wright DJ, Newman B, Gibble JW, Ameti DI, Nass CC, Schreiber GB, Nemo GJ.

J Infect Dis. 1997 Dec;176(6):1468-75.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk